TY - JOUR
T1 - Pharmacological survey of medicinal plants for activity at ligand-gated ion channels
T2 - Selective interaction with 5-HT3 receptors
AU - Luedtke, Robert R.
AU - Bell-Horner, Cathy L.
AU - Volk, Michael
AU - Reinecke, Manfred G.
AU - Dillon, Glenn H.
N1 - Funding Information:
This work was supported by a grant from the National Institute on Drug Abuse (R O1 DA 12205) and the Texas Christian University Research Fund. Chinese plants were provided by Drs. Yuying Zhao, Yong-hua Shu and Qi Jia of the Department of Phytochemistry of the Beijing College of Medicine. Bolivian plants were obtained by Dr. Joseph Bastien of the Department of Anthropology of the University of Texas at Arlington and Dr. Jaime Zalles-Asin of Eservicio Integrado en Salud of La Paz, Bolivia. Pakistani plants were obtained from Professor Mohammad Arfan of the University of Peshawar, Pakistan. Literature searching was aided by the use of the NAPRALERT(SM) database.
PY - 2004/2
Y1 - 2004/2
N2 - The ligand-gated anion-selective ion channels are part of a superfamily of ligand-gated ion channels (LGICs) that are responsible for a majority of inhibitory signaling in the central nervous system and are the targets of numerous therapeutics. Aqueous, organic and alcoholic extracts of 47 Chinese, Bolivian and Pakistani medicinal plants were evaluated for the ability to modulate the activity of GABA A receptors. Extracts were initially screened for their ability to modulate activity of α1β2γ2 GABA A receptors expressed in HEK 293 cells. Based on the initial screen, two extracts derived from members of the Asteraceae family, Xanthium spinosum and Senecio mathewsii, were chosen for more detailed analysis. Xanthium spinosum inhibited GABA A receptor function, with an IC 50 of 50 ± 10μg/ml, while Senecio mathewsii inhibited GABA A receptor activity with an IC 50 of 35 ± 3.0μg/ml. To assess the selectivity of interaction, these extracts were also tested on two other members of the LGIC superfamily a) glycine receptors, a distinct inhibitory neurotransmitter receptor and b) 5-HT3A receptors, a cation-selective receptor. At a concentration of Xanthium spinosum that blocked 70% of GABA-activated current, only 15% of glycine-gated current, recorded from recombinant α1 glycine receptors, was blocked, suggesting a lower affinity of Xanthium spinosum for glycine receptors. Senecio mathewsii had larger inhibitory effects on glycine receptors than Xanthium spinosum, although the apparent affinity still was estimated to be three-fold lower than that seen for GABA A receptors. Xanthium spinosum and Senecio mathewsii also inhibited 5-HT3A receptor functions. Notably, the IC 50 of both extracts was seven to ten-fold lower than that observed for GABA A receptors. Thus, the rank order of potency for organic extracts from both Xanthium spinosum and Senecio mathewsii was 5-HT3A receptors > GABA A receptors > glycine receptors. Therefore, these extracts may be a source of novel compounds that may serve as lead molecules for the development of novel 5-HT3 receptor antagonists.
AB - The ligand-gated anion-selective ion channels are part of a superfamily of ligand-gated ion channels (LGICs) that are responsible for a majority of inhibitory signaling in the central nervous system and are the targets of numerous therapeutics. Aqueous, organic and alcoholic extracts of 47 Chinese, Bolivian and Pakistani medicinal plants were evaluated for the ability to modulate the activity of GABA A receptors. Extracts were initially screened for their ability to modulate activity of α1β2γ2 GABA A receptors expressed in HEK 293 cells. Based on the initial screen, two extracts derived from members of the Asteraceae family, Xanthium spinosum and Senecio mathewsii, were chosen for more detailed analysis. Xanthium spinosum inhibited GABA A receptor function, with an IC 50 of 50 ± 10μg/ml, while Senecio mathewsii inhibited GABA A receptor activity with an IC 50 of 35 ± 3.0μg/ml. To assess the selectivity of interaction, these extracts were also tested on two other members of the LGIC superfamily a) glycine receptors, a distinct inhibitory neurotransmitter receptor and b) 5-HT3A receptors, a cation-selective receptor. At a concentration of Xanthium spinosum that blocked 70% of GABA-activated current, only 15% of glycine-gated current, recorded from recombinant α1 glycine receptors, was blocked, suggesting a lower affinity of Xanthium spinosum for glycine receptors. Senecio mathewsii had larger inhibitory effects on glycine receptors than Xanthium spinosum, although the apparent affinity still was estimated to be three-fold lower than that seen for GABA A receptors. Xanthium spinosum and Senecio mathewsii also inhibited 5-HT3A receptor functions. Notably, the IC 50 of both extracts was seven to ten-fold lower than that observed for GABA A receptors. Thus, the rank order of potency for organic extracts from both Xanthium spinosum and Senecio mathewsii was 5-HT3A receptors > GABA A receptors > glycine receptors. Therefore, these extracts may be a source of novel compounds that may serve as lead molecules for the development of novel 5-HT3 receptor antagonists.
KW - Antiemetic
KW - Cation channel
KW - Natural products
KW - Serotonin antagonist
KW - Serotonin receptor
UR - http://www.scopus.com/inward/record.url?scp=9444276591&partnerID=8YFLogxK
U2 - 10.1080/13880200490505654
DO - 10.1080/13880200490505654
M3 - Article
AN - SCOPUS:9444276591
SN - 1388-0209
VL - 42
SP - 73
EP - 82
JO - Pharmaceutical Biology
JF - Pharmaceutical Biology
IS - 1
ER -